We serve Chemical Name:chembrdg-bb 4000145 CAS:89581-61-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:chembrdg-bb 4000145
CAS.NO:89581-61-3
Synonyms:chembrdg-bb 4000145
Molecular Formula:C6H5ClN2O3
Molecular Weight:188.56800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:373.1ºC at 760 mmHg
Density:1.6g/cm3
Index of Refraction:1.631
PSA:72.19000
Exact Mass:187.99900
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like chembrdg-bb 4000145 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chembrdg-bb 4000145 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chembrdg-bb 4000145 Use and application,chembrdg-bb 4000145 technical grade,usp/ep/jp grade.
Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. chembrdg-bb 4000145 manufacturer From basic chemical raw materials to chemical preparations, complex chemical and physical processes are required. The production of chemical raw materials and intermediates concentrates the main synthetic procedures and technical links, which is the prerequisite and important guarantee for the development of the chemical pharmaceutical industry. chembrdg-bb 4000145 supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. chembrdg-bb 4000145 vendor There are also new directives that relate to US citizens. chembrdg-bb 4000145 factory There are also new directives that relate to US citizens.
